
Unanimous decision by the Fifth Panel reinforces patients' right to therapeutic planting upon medical proof and highlights the topic in an official report

The new deadline extends the time for the government to finalize the regulation of cannabis cultivation for the production of medicines in the country

Minister Regina Helena Costa states that this will be the last extension and orders Anvisa to report compliance with each intermediate step of the plan

First Section's trial will take place on Thursday (06); decision impacts cannabis regulation in the country

Facing the Federal Government's request for a 180-day extension to regulate cannabis, experts analyze the possible scenarios at STJ, ranging from granting the extension to imposing fines for non-compliance

STJ Minister demands Union and Anvisa to execute the Action Plan for the medicinal cultivation of the plant

After receiving an action plan from the Union, the 1st Section of the STJ extends the deadline for delivering regulations on the production and access to cannabis for medicinal use

Decision reaffirms the six-month deadline for implementing rules on hemp for medicinal, pharmaceutical, and industrial use

Historic decision establishes parameters for the production of industrial hemp for medicinal and pharmaceutical purposes. The Union has yet to comment on deadlines.

Unprecedented decision by the Superior Court of Justice allows a group from Peruíbe (SP) to cultivate cannabis for therapeutic purposes, paving the way for new legal and medical debates on the medicinal use of the plant

Court relied on Anvisa resolution to justify favorable opinion

Company demands urgent measures in face of new missed deadlines by the government and Anvisa and proposes experimental environment under judicial supervision

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Ministry of Health and Anvisa claim technical complexity and propose a new schedule that extends until March 2026 to define the rules

Representatives of associations that participated in the meeting with the agency confirmed the delivery of the draft ordinance by September 30; Anvisa has not yet officially stated whether it will comply with the court's deadline, which ends today.

The Reporting Minister, Herman Benjamin, acknowledged that no subconstitutional laws are being violated, maintaining what had already been decided at the 5th Region Federal Regional Court (TRF-5)

Document presents preliminary guidelines for authorization of cultivation by legal entities and control mechanisms

STJ decision reinforces federal competence for actions involving unregistered drugs at the regulatory agency

STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency

STJ grants safe-conduct to patient with anxiety disorder to import seeds and cultivate medicinal cannabis, reinforcing the right to health and paving the way for new precedents in the country